Paulina Pabian, mgr inż.
Paulina Pabian, mgr inż.
Achievements
- Publications
Modulating Stress Susceptibility and Resilience: Insights from miRNA Manipulation and Neural Mechanisms in Mice
Autorzy: J. Solich, M. Kolasa, A. Faron-Górecka, P. Pabian, K. Latocha, A. Korlatowicz, M. Dziedzicka-Wasylewska
DOI: 10.1007/s12035-024-03922-1
Date: 2024-09-01
Restraint Stress in Mice Alters Set of 25 miRNAs Which Regulate Stress- and Depression-Related mRNAs
Autorzy: Joanna Solich, Maciej Kuśmider, Agata Faron-Górecka, Paulina Pabian, Marta Dziedzicka-Wasylewska
DOI: 10.3390/ijms21249469
Date: 2020-12-12
Time-course of changes in key catecholaminergic receptors and trophic systems in rat brain after antidepressant administration.
Autorzy:
DOI: 10.1016/j.neuint.2020.104885
Date: 2020-10-22
Serum Level of miR-1 and miR-155 as Potential Biomarkers of Stress-Resilience of NET-KO and SWR/J Mice.
Autorzy:
DOI: 10.3390/cells9040917
Date: 2020-04-09
Clozapine administered repeatedly following pretreatment with ketamine enhances dopamine D<sub>2</sub> receptors in the dopamine mesolimbic pathway in mice brain.
Autorzy:
DOI: 10.1016/j.neulet.2019.134292
Date: 2019-05-24
Behavioral response to imipramine under chronic mild stress corresponds with increase of mRNA encoding somatostatin receptors sst2 and sst4 expression in medial habenular nucleus.
Autorzy:
DOI: 10.1016/j.neuint.2018.10.002
Date: 2018-10-03
Regulation of somatostatin receptor 2 in the context of antidepressant treatment response in chronic mild stress in rat.
Autorzy:
DOI: 10.1007/s00213-018-4912-x
Date: 2018-04-30
Paroxetine and Low-dose Risperidone Induce Serotonin 5-HT1A and Dopamine D2 Receptor Heteromerization in the Mouse Prefrontal Cortex.
Autorzy:
DOI: 10.1016/j.neuroscience.2018.03.004
Date: 2018-03-12
Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex.
Autorzy:
DOI: 10.3389/fnmol.2018.00040
Date: 2018-02-15
Effects of imipramine on cytokines panel in the rats serum during the drug treatment and discontinuation.
Autorzy:
DOI: 10.1016/j.neuint.2017.11.016
Date: 2017-11-28